Optical Control of Cardiac Function with a Photoswitchable Muscarinic Agonist
- 22 April 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 141 (18) , 7628-7636
Abstract
Light-triggered reversible modulation of physiological functions offers the promise of enabling on-demand spatiotemporally controlled therapeutic interventions. Optogenetics has been successfully implemented in the heart, but significant barriers to its use in the clinic remain, such as the need for genetic transfection. Herein, we present a method to modulate cardiac function with light through a photoswitchable compound and without genetic manipulation. The molecule, named PAI, was designed by introduction of a photoswitch into the molecular structure of an M2 mAChR agonist. In vitro assays revealed that PAI enables light-dependent activation of M2 mAChRs. To validate the method, we show that PAI photoisomers display different cardiac effects in a mammalian animal model, and demonstrate reversible, real-time photocontrol of cardiac function in translucent wildtype tadpoles. PAI can also effectively activate M2 receptors using two-photon excitation with near-infrared light, which overcomes the scattering and low penetration of short-wave-length illumination, and offers new opportunities for intravital imaging and control of cardiac function.Keywords
All Related Versions
Funding Information
- Fundaci?n Ram?n Areces
- Horizon 2020 Framework Programme (785907)
- Ministerio de Econom?a y Competitividad ((FPI fellowship BES-2014-068169 and project CTQ201)
- Fundaluce foundation
- FEDER funds
- Ermenegildo Zegna Founder?s Scholarship
- ERANET SynBio MODULIGHTOR
- CATCH-ME ((grant agreement n? 633196))
- Recep-tor Dynamics ? Emerging paradigms for novel drugs
- AGAUR/Generalitat de Catalunya (CERCA Pro-gramme) (2017-SGR-1442 and 2017-SGR-1548)
This publication has 45 references indexed in Scilit:
- Optogenetic Modulation of Cardiac Sympathetic Nerve Activity to Prevent Ventricular ArrhythmiasJACC, 2017
- Light in diagnosis, therapy and surgeryNature Biomedical Engineering, 2017
- Will cardiac optogenetics find the way through the obscure angles of heart physiology?Biochemical and Biophysical Research Communications, 2017
- Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulationsJournal of Clinical Investigation, 2016
- Emerging Targets in PhotopharmacologyAngewandte Chemie International Edition, 2016
- Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatmentNature Reviews Cardiology, 2015
- “Beauty is a light in the heart”: The transformative potential of optogenetics for clinical applications in cardiovascular medicine1Trends in Cardiovascular Medicine, 2015
- Light-induced termination of spiral wave arrhythmias by optogenetic engineering of atrial cardiomyocytesCardiovascular Research, 2014
- Light‐Regulated Stapled Peptides to Inhibit Protein–Protein Interactions Involved in Clathrin‐Mediated EndocytosisAngewandte Chemie International Edition, 2013
- Optical modulation of neurotransmission using calcium photocurrents through the ion channel LiGluRFrontiers in Molecular Neuroscience, 2013